Innate Pharma (IPHA) Receivables - Other (2017 - 2025)
Innate Pharma (IPHA) reported Receivables - Other of $657684.6 for Q4 2025, up 591.54% on a YoY basis from $95105.0 in Q4 2024, and up 591.54% quarter-over-quarter from $95105.0 in Q4 2024.
Innate Pharma (IPHA) Receivables - Other (2017 - 2025) Analysis & Trends
Innate Pharma has reported Receivables - Other for 9 years, with the latest figure at $657684.6 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other rose 591.54% year-over-year to $657684.6; the trailing twelve-month figure through Dec 2025 stood at $657684.6 (up 591.54% YoY), and the FY2025 full-year result was $657684.6, up 591.54% from the prior year.
- Receivables - Other for Q4 2025 stood at $657684.6, up from $95105.0 in the prior quarter.
- The five-year high for Receivables - Other was $931192.4 in Q4 2021, with the low at $62235.1 in Q4 2022.
- Historically, Receivables - Other has averaged $371623.0 across 5 years, with a median of $111897.8 in 2023.
- Annual changes were most pronounced in 2022 — Receivables - Other plunged 93.32% — and 2025, when it soared 591.54%.
- Innate Pharma's Receivables - Other stood at $931192.4 in 2021, then sank by 93.32% to $62235.1 in 2022, then soared by 79.8% to $111897.8 in 2023, then decreased by 15.01% to $95105.0 in 2024, then soared by 591.54% to $657684.6 in 2025.
- The last three Receivables - Other figures came in at $657684.6 (Q4 2025), $95105.0 (Q4 2024), and $111897.8 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 657,684.59 |
| Dec 31, 2025 | 657,684.59 |
| Dec 31, 2024 | 95,104.99 |
| Dec 31, 2024 | 95,104.99 |
| Dec 31, 2023 | 111,897.75 |
| Dec 31, 2023 | 111,897.75 |
| Dec 31, 2022 | 62,235.09 |
| Dec 31, 2022 | 62,235.09 |
| Dec 31, 2021 | 931,192.35 |
| Dec 31, 2021 | 931,192.35 |
| Dec 31, 2020 | 883,486.78 |
| Dec 31, 2020 | 883,486.78 |
| Dec 31, 2019 | 602,146.89 |
| Dec 31, 2019 | 602,146.89 |
| Dec 31, 2018 | 123.94 Mn |
| Dec 31, 2018 | 123.94 Mn |
| Dec 31, 2017 | 163,663.12 |
| Dec 31, 2017 | 163,663.12 |